Jul 8, 2026 12:30PM
Jul 8, 2026 11:32AM
Jul 7, 2026 07:03AM
May 21, 2026 06:39AM
May 18, 2026 04:00PM
May 14, 2026 06:48AM
Mar 27, 2026 01:00PM This U.S. biotech stock is 'grossly undervalued', Bernstein says
Mar 26, 2026 08:29AM
Mar 25, 2026 04:11PM
Mar 25, 2026 01:09PM
Mar 25, 2026 01:00PM
Mar 25, 2026 12:57PM
Mar 25, 2026 11:48AM
Mar 3, 2026 07:21AM H.C. Wainwright Reiterates Buy Rating on Beam Therapeutics Inc (BEAM)
Feb 26, 2026 05:52AM
Feb 24, 2026 11:49AM
Feb 20, 2026 06:46AM
Feb 3, 2026 11:34AM
Jan 21, 2026 07:44AM
Jan 15, 2026 06:43AM
Jan 12, 2026 07:54AM Beam Therapeutics (BEAM) Reiterated at Overweight by Cantor Fitzgerald
Jan 12, 2026 07:25AM
Jan 12, 2026 04:04AM
Jan 7, 2026 12:40AM
Nov 17, 2025 09:15AM
Nov 4, 2025 03:27PM
Nov 4, 2025 08:02AM
Oct 31, 2025 09:54AM FDA Clears Way for Faster Personalized Gene Editing Treatments
Oct 9, 2025 12:12PM
Sep 15, 2025 07:33AM
Aug 30, 2025 04:00PM
Aug 19, 2025 06:56AM
Aug 14, 2025 07:00AM
Aug 7, 2025 11:35AM
Aug 5, 2025 12:49PM Clear Street Reiterates Buy Rating on Beam Therapeutics Inc (BEAM)
Jul 1, 2025 06:51AM
Jun 18, 2025 12:15PM
Jun 17, 2025 11:28AM
Jun 16, 2025 06:37AM
Jun 13, 2025 07:00AM
Jun 3, 2025 07:00AM
May 29, 2025 04:02PM Beam Therapeutics (BEAM) Announces U.S. FDA Orphan Drug Designation Granted to BEAM-302 for the Treatment of Alpha-1 Antitrypsin Deficiency
May 12, 2025 04:05PM
May 6, 2025 07:36AM
Apr 22, 2025 03:20PM
Apr 10, 2025 05:32AM
Apr 7, 2025 06:40AM
Mar 28, 2025 06:19AM
Mar 27, 2025 04:01PM Beam Therapeutics (BEAM) Announces Clearance of Investigational New Drug Application for BEAM-302 for the Treatment of Alpha-1 Antitrypsin Deficiency
Mar 25, 2025 09:44AM

429,992 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All